AVESTIN EmulsiFlex-C5 High-Pressure Homogenizer
| Brand | AVESTIN |
|---|---|
| Origin | Canada |
| Manufacturer | Avestin Inc., Ottawa, Canada |
| Model | EmulsiFlex-C5 |
| Instrument Type | High-Pressure Homogenizer |
| Operating Pressure Range | 500–30,000 psi (3.4–207 MPa) |
| Sample Volume Range | 7–5,000 mL |
| Flow Rate | 1–5 L/h |
| Dimensions (W×D×H) | 100 × 200 × 300 mm |
| Drive System | Pneumatic Single Plunger |
| Homogenizing Valve | Wear-Resistant Ceramic |
| Temperature Control Range | −25 to 200 °C (via external bath) |
| Sterilization | SIP (Steam-in-Place) and CIP (Clean-in-Place) compliant |
| Materials | Electropolished 316L stainless steel and FDA-compliant ceramic components |
| Regulatory Compliance | Designed and validated per GMP, FDA 21 CFR Part 11 (audit trail capable), ISO 13485, and USP <1043> for sterile processing equipment |
Overview
The AVESTIN EmulsiFlex-C5 is a benchtop high-pressure homogenizer engineered for precision nanoscale particle size reduction and cell disruption in regulated R&D and pilot-scale manufacturing environments. It operates on the principle of controlled microfluidic shear, cavitation, and impact forces generated when pressurized sample streams are forced through a precisely engineered ceramic homogenizing valve at pressures up to 30,000 psi (207 MPa). Unlike rotor-stator or ultrasonic systems, this hydrodynamic mechanism delivers consistent, scalable, and thermally controllable disruption—critical for preserving labile biomolecules, liposomes, mRNA-LNPs, and protein complexes. Its compact footprint (100 × 200 × 300 mm), low minimum sample volume (7 mL), and full GMP-aligned architecture make it suitable for early-stage formulation development, process characterization, and quality-by-design (QbD) studies under ICH Q5A–Q5E and FDA guidance.
Key Features
- Ultra-high pressure capability: Adjustable operating range from 500 to 30,000 psi (3.4–207 MPa), enabling reproducible sub-100 nm particle size distributions in liposomal, nanoemulsion, and nanocrystalline formulations.
- GMP-integrated fluid path: Entire product-contact surface electropolished to Ra ≤ 0.4 µm; no elastomeric seals in the high-pressure zone; all wetted materials comply with USP Class VI and FDA 21 CFR 177.2600 for food-contact and pharmaceutical use.
- Contamination-free drive system: Self-lubricating pneumatic plunger eliminates need for water-based lubrication—removing a primary source of microbial ingress and cross-contamination.
- Non-invasive pressure monitoring: Diaphragm-type pressure transducer (not Bourdon-tube gauge) ensures oil-free, sterile pressure feedback compatible with 21 CFR Part 11 audit trails.
- Integrated thermal management: Compatible with external recirculating chillers or heating baths for precise temperature control between −25 °C and +200 °C—essential for heat-sensitive biologics and thermolabile APIs.
- Validatable sterilization: Full SIP (steam-in-place) and CIP (clean-in-place) functionality supported by ASME BPE-compliant tubing, traceable temperature/pressure logging, and documented cycle validation protocols.
Sample Compatibility & Compliance
The EmulsiFlex-C5 accommodates aqueous suspensions, organic-aqueous emulsions, viscous polymer solutions (up to 10,000 cP), and fragile biological matrices including mammalian cells, yeast, E. coli, and plant tissue lysates. Its ceramic valve and polished 316L stainless-steel flow path resist corrosion from acidic, alkaline, or halogenated solvents. The system conforms to ISO 22000 (food safety), ASTM F2897 (nanomaterial dispersion testing), and ICH Q5A(R2) for viral clearance validation. All documentation—including material certifications, weld logs, surface finish reports, and factory acceptance test (FAT) records—is provided in English and supports FDA pre-submission audits and EU Annex 15 qualification.
Software & Data Management
While the EmulsiFlex-C5 operates via analog pressure regulation and manual flow control, its architecture supports integration with third-party SCADA or MES platforms via 4–20 mA analog outputs for pressure, temperature, and flow rate. Optional digital retrofit kits enable real-time data logging (with timestamp, operator ID, and parameter setpoints) compliant with 21 CFR Part 11 requirements—including electronic signatures, audit trails, and role-based access control. Raw data files are exportable in CSV or XML format for statistical process control (SPC), DOE analysis, and regulatory submission packages.
Applications
- Cell lysis and inclusion body solubilization for recombinant protein purification
- Liposome extrusion and size homogenization for mRNA vaccine carriers
- Nanocrystal formation of poorly water-soluble drugs (BCS Class II/IV)
- Stable nanoemulsion development for topical, oral, and IV delivery
- Disruption of Gram-negative and Gram-positive bacteria for antigen extraction
- Homogenization of plant extracts and natural product suspensions under cold conditions
FAQ
What is the minimum viable sample volume for method development?
The EmulsiFlex-C5 supports reproducible processing down to 7 mL—ideal for high-value APIs, clinical trial batches, and screening studies where material conservation is critical.
Can the system be qualified for GMP manufacturing use?
Yes. The unit ships with IQ/OQ documentation templates aligned with ASTM E2500 and ISPE GAMP5. Installation includes vendor-led FAT/SAT, surface finish verification, and pressure decay leak testing.
Is ceramic valve replacement required after each batch?
No. The sintered zirconia-toughened alumina valve demonstrates >500 hours of continuous operation at 25,000 psi before measurable wear—validated per ISO 13320 laser diffraction trending.
How is temperature stability maintained during extended processing?
Via external jacketed circulation: users connect the integrated cooling/heating ports to a programmable chiller or oil bath with ±0.5 °C stability over 8-hour runs.
Does AVESTIN provide support for regulatory submissions?
Yes. AVESTIN supplies URS, DQ/IQ/OQ protocols, material traceability dossiers, and engineering change control history—fully editable for inclusion in IND, NDA, or MAA dossiers.

